WO1991009935A1 - Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen - Google Patents
Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen Download PDFInfo
- Publication number
- WO1991009935A1 WO1991009935A1 PCT/AT1990/000128 AT9000128W WO9109935A1 WO 1991009935 A1 WO1991009935 A1 WO 1991009935A1 AT 9000128 W AT9000128 W AT 9000128W WO 9109935 A1 WO9109935 A1 WO 9109935A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- virus
- cells
- antigen
- matrix
- bound
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 91
- 239000000427 antigen Substances 0.000 title claims abstract description 53
- 102000036639 antigens Human genes 0.000 title claims abstract description 53
- 108091007433 antigens Proteins 0.000 title claims abstract description 53
- 239000011159 matrix material Substances 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims description 19
- 230000008569 process Effects 0.000 title claims description 4
- 210000004027 cell Anatomy 0.000 claims abstract description 69
- 239000002609 medium Substances 0.000 claims abstract description 14
- 210000003501 vero cell Anatomy 0.000 claims abstract description 11
- 206010014599 encephalitis Diseases 0.000 claims abstract description 8
- 201000011475 meningoencephalitis Diseases 0.000 claims abstract description 7
- 230000001419 dependent effect Effects 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims description 23
- 230000010412 perfusion Effects 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 239000012679 serum free medium Substances 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 3
- 241000710831 Flavivirus Species 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 241000712891 Arenavirus Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000035899 viability Effects 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 abstract description 8
- 238000004113 cell culture Methods 0.000 abstract description 4
- 210000004102 animal cell Anatomy 0.000 abstract description 3
- 210000005260 human cell Anatomy 0.000 abstract description 3
- 230000002779 inactivation Effects 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 239000000758 substrate Substances 0.000 abstract 3
- 241000710771 Tick-borne encephalitis virus Species 0.000 abstract 2
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 208000004006 Tick-borne encephalitis Diseases 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 241000867607 Chlorocebus sabaeus Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT91900666T ATE113652T1 (de) | 1989-12-22 | 1990-12-21 | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen. |
EP19910900666 EP0506714B1 (de) | 1989-12-22 | 1990-12-21 | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen |
DE59007659T DE59007659D1 (de) | 1989-12-22 | 1990-12-21 | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen. |
SU905052769A RU2082757C1 (ru) | 1989-12-22 | 1990-12-21 | Субстрат для культивирования флавивирусов или ареновирусов на основе культуры клеток и способ получения антигена флавивируса или ареновируса |
FI922851A FI98377C (fi) | 1989-12-22 | 1992-06-18 | Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi |
NO19922422A NO310305B1 (no) | 1989-12-22 | 1992-06-19 | Matrise med adherent bundede celler, samt fremgangsmåte ved fremstilling av forsommer-meningo-encefalitis-(FSME)-virus-antigen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT2928/89A AT393356B (de) | 1989-12-22 | 1989-12-22 | Verfahren zur herstellung von fsme-virus-antigen |
ATA2928/89 | 1989-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1991009935A1 true WO1991009935A1 (de) | 1991-07-11 |
Family
ID=3542524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AT1990/000128 WO1991009935A1 (de) | 1989-12-22 | 1990-12-21 | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0506714B1 (de) |
JP (1) | JP2633391B2 (de) |
AT (2) | AT393356B (de) |
CA (1) | CA2071954C (de) |
CZ (1) | CZ281804B6 (de) |
DE (1) | DE59007659D1 (de) |
DK (1) | DK0506714T3 (de) |
ES (1) | ES2067916T3 (de) |
FI (1) | FI98377C (de) |
HR (1) | HRP921354A2 (de) |
HU (1) | HU213886B (de) |
NO (1) | NO310305B1 (de) |
RU (1) | RU2082757C1 (de) |
SK (1) | SK659090A3 (de) |
WO (1) | WO1991009935A1 (de) |
YU (1) | YU242390A (de) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737412A1 (fr) * | 1995-08-01 | 1997-02-07 | Pasteur Merieux Serums Vacc | Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede |
WO1997004803A1 (fr) * | 1995-08-01 | 1997-02-13 | Pasteur Merieux Serums & Vaccins | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu |
EP1057889A1 (de) * | 1998-10-05 | 2000-12-06 | The Research Foundation for Microbial Diseases of Osaka University | Verbessertes immunogen für inaktivierten impfstoff gegen infektion mit japanischen encephalitis viren und verfahren zu dessen herstellung |
EP1213030A1 (de) * | 1994-11-10 | 2002-06-12 | Baxter Aktiengesellschaft | Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur |
WO2003054174A1 (en) * | 2001-12-10 | 2003-07-03 | Baxter Healthcare S.A. | Method for large scale production of virus antigen |
WO2003049767A3 (en) * | 2001-12-10 | 2004-03-11 | Baxter Healthcare Sa | Method of large scale production of hepatitis a virus |
US8021881B2 (en) | 1999-09-28 | 2011-09-20 | Baxter Innovations Gmbh | Medium for the protein-free and serum-free cultivation of cells |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
PT2235197T (pt) * | 2007-12-27 | 2017-10-11 | Baxalta Inc | Processos para cultura de células |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2444466A1 (fr) * | 1978-12-22 | 1980-07-18 | Immuno Ag | Procede de fabrication de vaccins contre le virus de la meningoencephalite du debut de l'ete (virus fsme) et vaccins ainsi obtenus |
GB2059991A (en) * | 1979-09-12 | 1981-04-29 | Pharmacia Fine Chemicals Ab | Cultivating cells on particulate microcarriers |
GB2094832A (en) * | 1981-03-13 | 1982-09-22 | Damon Corp | Process for culturing anchorage dependent cells |
EP0066726A1 (de) * | 1981-05-19 | 1982-12-15 | Pharmacia Ab | Verwendung einer in Wasser schwellbaren aber nicht löslichen polymeren Substanz mit quaternären Stickstoffgruppen, als Mikroträger zur Züchtung von fixationsabhängigen Zellen |
GB2151610A (en) * | 1981-12-21 | 1985-07-24 | Kms Fusion Inc | Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture |
EP0239648A1 (de) * | 1985-10-03 | 1987-10-07 | Nauchno-Proizvodstvennoe Obiedinenie "Biolar" | Herstellungsverfahren für mikroträger zur zucht von zellen und so erhaltene mikroträger |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT385203B (de) * | 1985-04-26 | 1988-03-10 | Immuno Ag | Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine |
-
1989
- 1989-12-22 AT AT2928/89A patent/AT393356B/de not_active IP Right Cessation
-
1990
- 1990-12-21 CA CA 2071954 patent/CA2071954C/en not_active Expired - Lifetime
- 1990-12-21 SK SK6590-90A patent/SK659090A3/sk not_active IP Right Cessation
- 1990-12-21 JP JP50113291A patent/JP2633391B2/ja not_active Expired - Fee Related
- 1990-12-21 WO PCT/AT1990/000128 patent/WO1991009935A1/de active IP Right Grant
- 1990-12-21 DK DK91900666T patent/DK0506714T3/da not_active Application Discontinuation
- 1990-12-21 HU HU9202009A patent/HU213886B/hu unknown
- 1990-12-21 YU YU242390A patent/YU242390A/sh unknown
- 1990-12-21 DE DE59007659T patent/DE59007659D1/de not_active Expired - Fee Related
- 1990-12-21 RU SU905052769A patent/RU2082757C1/ru not_active IP Right Cessation
- 1990-12-21 CZ CS906590A patent/CZ281804B6/cs not_active IP Right Cessation
- 1990-12-21 ES ES91900666T patent/ES2067916T3/es not_active Expired - Lifetime
- 1990-12-21 EP EP19910900666 patent/EP0506714B1/de not_active Expired - Lifetime
- 1990-12-21 AT AT91900666T patent/ATE113652T1/de not_active IP Right Cessation
-
1992
- 1992-06-18 FI FI922851A patent/FI98377C/fi active
- 1992-06-19 NO NO19922422A patent/NO310305B1/no not_active IP Right Cessation
- 1992-11-25 HR HRP921354 patent/HRP921354A2/xx not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2444466A1 (fr) * | 1978-12-22 | 1980-07-18 | Immuno Ag | Procede de fabrication de vaccins contre le virus de la meningoencephalite du debut de l'ete (virus fsme) et vaccins ainsi obtenus |
GB2059991A (en) * | 1979-09-12 | 1981-04-29 | Pharmacia Fine Chemicals Ab | Cultivating cells on particulate microcarriers |
GB2094832A (en) * | 1981-03-13 | 1982-09-22 | Damon Corp | Process for culturing anchorage dependent cells |
EP0066726A1 (de) * | 1981-05-19 | 1982-12-15 | Pharmacia Ab | Verwendung einer in Wasser schwellbaren aber nicht löslichen polymeren Substanz mit quaternären Stickstoffgruppen, als Mikroträger zur Züchtung von fixationsabhängigen Zellen |
GB2151610A (en) * | 1981-12-21 | 1985-07-24 | Kms Fusion Inc | Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture |
EP0239648A1 (de) * | 1985-10-03 | 1987-10-07 | Nauchno-Proizvodstvennoe Obiedinenie "Biolar" | Herstellungsverfahren für mikroträger zur zucht von zellen und so erhaltene mikroträger |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1213030A1 (de) * | 1994-11-10 | 2002-06-12 | Baxter Aktiengesellschaft | Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur |
WO1997004803A1 (fr) * | 1995-08-01 | 1997-02-13 | Pasteur Merieux Serums & Vaccins | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu |
US6149917A (en) * | 1995-08-01 | 2000-11-21 | Pasteur Merieux Serums Et Vaccins | Industrial production process for a vaccine against Japanese encephalitis virus and vaccine produced |
CN1122531C (zh) * | 1995-08-01 | 2003-10-01 | 巴斯德梅诺血清和疫苗公司 | 抗日本脑炎疫苗的工业生产方法和所获得的疫苗 |
FR2737412A1 (fr) * | 1995-08-01 | 1997-02-07 | Pasteur Merieux Serums Vacc | Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede |
EP1057889A1 (de) * | 1998-10-05 | 2000-12-06 | The Research Foundation for Microbial Diseases of Osaka University | Verbessertes immunogen für inaktivierten impfstoff gegen infektion mit japanischen encephalitis viren und verfahren zu dessen herstellung |
EP1057889A4 (de) * | 1998-10-05 | 2002-01-23 | Univ Osaka Res Found | Verbessertes immunogen für inaktivierten impfstoff gegen infektion mit japanischen encephalitis viren und verfahren zu dessen herstellung |
US6841374B1 (en) | 1998-10-05 | 2005-01-11 | Research Foundation For Microbial Diseases Of Osaka University | Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same |
US8021881B2 (en) | 1999-09-28 | 2011-09-20 | Baxter Innovations Gmbh | Medium for the protein-free and serum-free cultivation of cells |
US9982286B2 (en) | 1999-09-28 | 2018-05-29 | Baxalta Incorporated | Medium for the protein-free and serum-free cultivation of cells |
US9441203B2 (en) | 1999-09-28 | 2016-09-13 | Baxalta Innovations Gmbh | Medium for the protein-free and serum-free cultivation of cells |
US8722406B2 (en) | 1999-09-28 | 2014-05-13 | Baxter Innovations Gmbh | Medium for the protein-free and serum-free cultivation of cells |
WO2003049767A3 (en) * | 2001-12-10 | 2004-03-11 | Baxter Healthcare Sa | Method of large scale production of hepatitis a virus |
US7524676B2 (en) | 2001-12-10 | 2009-04-28 | Baxter Healthcare S.A. | Large scale productions of virus antigen |
EP2330189A1 (de) * | 2001-12-10 | 2011-06-08 | Baxter Healthcare S.A. | Verfahren zur Produktion von Viren im Grossmassstab |
EP1894998A1 (de) * | 2001-12-10 | 2008-03-05 | Baxter Healthcare S.A. | Verbessertes Verfahren zur Massenherstellung von Viren |
AU2002358663B2 (en) * | 2001-12-10 | 2007-09-13 | Baxter Healthcare S.A. | Method of large scale production of Hepatitis A Virus |
US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
WO2003054174A1 (en) * | 2001-12-10 | 2003-07-03 | Baxter Healthcare S.A. | Method for large scale production of virus antigen |
Also Published As
Publication number | Publication date |
---|---|
HRP921354A2 (en) | 1996-02-29 |
CZ281804B6 (cs) | 1997-02-12 |
HU213886B (en) | 1997-11-28 |
NO922422D0 (no) | 1992-06-19 |
FI922851A (fi) | 1992-06-18 |
SK279236B6 (sk) | 1998-08-05 |
EP0506714A1 (de) | 1992-10-07 |
HUT65410A (en) | 1994-06-28 |
JP2633391B2 (ja) | 1997-07-23 |
FI98377C (fi) | 1997-06-10 |
CZ659090A3 (en) | 1996-11-13 |
DE59007659D1 (de) | 1994-12-08 |
YU242390A (sh) | 1993-05-28 |
JPH05502581A (ja) | 1993-05-13 |
FI922851A0 (fi) | 1992-06-18 |
DK0506714T3 (da) | 1995-04-18 |
HU9202009D0 (en) | 1992-10-28 |
ATE113652T1 (de) | 1994-11-15 |
CA2071954A1 (en) | 1991-06-23 |
SK659090A3 (en) | 1998-08-05 |
FI98377B (fi) | 1997-02-28 |
NO922422L (no) | 1992-08-17 |
EP0506714B1 (de) | 1994-11-02 |
RU2082757C1 (ru) | 1997-06-27 |
CA2071954C (en) | 1996-06-18 |
ES2067916T3 (es) | 1995-04-01 |
NO310305B1 (no) | 2001-06-18 |
ATA292889A (de) | 1991-03-15 |
AT393356B (de) | 1991-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1427817B1 (de) | Vermehrung von viren in zellkultur | |
DE19612966B4 (de) | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren | |
EP2011862B1 (de) | Verfahren zur Herstellung eines aktiven Bestandteils eines Arznei- oder Diagnosemittels im MDCK-Zell-Suspensionskultur | |
EP0531911B1 (de) | Kultivierung von Vero-Zellen | |
DE3833925A1 (de) | Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu | |
EP0506714B1 (de) | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen | |
EP1797174B1 (de) | Verfahren zur herstellung von virusmaterial | |
DE60222296T2 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
DE2828073C2 (de) | Verfahren zum Kultivieren von Viren | |
US3935066A (en) | Cell lines | |
CH615947A5 (en) | Process for the cultivation of anchorage-dependent cells in a microcarrier culture, microcarriers for carrying it out and use of the process. | |
DE2425997A1 (de) | Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin | |
DE60025036T2 (de) | Verfahren zur züchtung von haftenden tierischen zellen | |
DE2320885A1 (de) | Verbesserungen bei zell- und viruskultursystemen | |
EP0417531A1 (de) | Verfahren zur Herstellung von biologischen Materialien in Zellkulturen und Vorrichtungen | |
DE2812989A1 (de) | Verfahren zur herstellung von interferon und das dabei erhaltene produkt | |
EP0223218A2 (de) | Konditionierte Makrophagen und Verfahren zu ihrer Herstellung | |
DD213351A1 (de) | Verfahren zur herstellung von nichtparenteralen inaktivimpfstoffen gegen viren | |
DE1130558B (de) | Verfahren zur Herstellung eines Masernimpfstoffes | |
DD271057A1 (de) | Verfahren zur herstellung von tollwutimpfstoffen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA FI HU JP NO SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 922851 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2071954 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991900666 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1991900666 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1991900666 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 922851 Country of ref document: FI |